MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 280 filers reported holding MYRIAD GENETICS INC in Q3 2014. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,294,348 | +43144833.3% | 80,695 | -16.7% | 0.01% | – |
Q2 2023 | $3 | -99.8% | 96,838 | +9.7% | 0.00% | -100.0% |
Q4 2022 | $1,638 | -99.9% | 88,269 | -13.3% | 0.01% | -18.8% |
Q3 2022 | $1,921,000 | -22.1% | 101,784 | -6.1% | 0.02% | -20.0% |
Q2 2022 | $2,466,000 | +1.5% | 108,409 | +2.4% | 0.02% | +11.1% |
Q1 2022 | $2,429,000 | -12.8% | 105,819 | -1.1% | 0.02% | -10.0% |
Q4 2021 | $2,784,000 | -22.6% | 106,964 | -3.5% | 0.02% | -9.1% |
Q3 2021 | $3,596,000 | -5.7% | 110,798 | -1.5% | 0.02% | -4.3% |
Q2 2021 | $3,813,000 | +9.0% | 112,499 | -3.2% | 0.02% | +9.5% |
Q1 2021 | $3,498,000 | +10.2% | 116,219 | -2.5% | 0.02% | +5.0% |
Q4 2020 | $3,175,000 | +83.2% | 119,221 | +0.5% | 0.02% | +53.8% |
Q3 2020 | $1,733,000 | +22.0% | 118,664 | -0.2% | 0.01% | +18.2% |
Q2 2020 | $1,421,000 | -13.1% | 118,889 | +5.5% | 0.01% | -26.7% |
Q1 2020 | $1,635,000 | -47.5% | 112,740 | +2.3% | 0.02% | -37.5% |
Q4 2019 | $3,116,000 | -13.1% | 110,195 | +0.5% | 0.02% | -14.3% |
Q3 2019 | $3,585,000 | +24.8% | 109,680 | +0.4% | 0.03% | +21.7% |
Q2 2019 | $2,872,000 | -23.7% | 109,217 | -3.2% | 0.02% | -23.3% |
Q1 2019 | $3,762,000 | +15.0% | 112,869 | -4.8% | 0.03% | +7.1% |
Q4 2018 | $3,270,000 | -33.2% | 118,553 | +5.0% | 0.03% | -28.2% |
Q3 2018 | $4,895,000 | -3.4% | 112,939 | -4.5% | 0.04% | +11.4% |
Q2 2018 | $5,066,000 | +43.9% | 118,315 | -2.4% | 0.04% | +40.0% |
Q1 2018 | $3,521,000 | -26.8% | 121,244 | +1.8% | 0.02% | -21.9% |
Q4 2017 | $4,808,000 | +16.2% | 119,091 | -0.9% | 0.03% | +6.7% |
Q3 2017 | $4,138,000 | +43.8% | 120,117 | +0.9% | 0.03% | +36.4% |
Q2 2017 | $2,877,000 | +27.4% | 119,088 | -3.3% | 0.02% | +29.4% |
Q1 2017 | $2,258,000 | +167.2% | 123,185 | +138.0% | 0.02% | +142.9% |
Q4 2016 | $845,000 | -19.2% | 51,750 | +4.8% | 0.01% | -22.2% |
Q3 2016 | $1,046,000 | -27.9% | 49,402 | +0.3% | 0.01% | -30.8% |
Q2 2016 | $1,451,000 | -24.3% | 49,251 | 0.0% | 0.01% | -23.5% |
Q1 2016 | $1,918,000 | -7.4% | 49,251 | +0.7% | 0.02% | -15.0% |
Q4 2015 | $2,071,000 | +12.9% | 48,923 | -0.0% | 0.02% | +17.6% |
Q3 2015 | $1,834,000 | -45.0% | 48,925 | -50.1% | 0.02% | +21.4% |
Q2 2015 | $3,332,000 | +91.8% | 98,072 | +99.9% | 0.01% | -6.7% |
Q1 2015 | $1,737,000 | -48.1% | 49,070 | -50.1% | 0.02% | +7.1% |
Q4 2014 | $3,350,000 | +75.3% | 98,336 | +98.5% | 0.01% | -17.6% |
Q3 2014 | $1,911,000 | -2.7% | 49,537 | -1.8% | 0.02% | 0.0% |
Q2 2014 | $1,964,000 | +1.5% | 50,454 | -10.8% | 0.02% | +13.3% |
Q1 2014 | $1,935,000 | +60.4% | 56,583 | -1.6% | 0.02% | +66.7% |
Q4 2013 | $1,206,000 | -31.1% | 57,483 | -22.9% | 0.01% | -25.0% |
Q3 2013 | $1,751,000 | +3.2% | 74,527 | +18.0% | 0.01% | -14.3% |
Q2 2013 | $1,696,000 | – | 63,134 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 5,000,000 | $90,850,000 | 3.94% |
Altium Capital Management LP | 221,000 | $4,016,000 | 1.61% |
DISCIPLINED GROWTH INVESTORS INC /MN | 1,900,787 | $34,537,000 | 0.93% |
Zebra Capital Management LLC | 15,352 | $279,000 | 0.82% |
PFM Health Sciences, LP | 1,177,250 | $21,391,000 | 0.82% |
EARNEST PARTNERS LLC | 6,462,138 | $117,417,000 | 0.78% |
Glenview Capital Management | 1,696,791 | $30,831,000 | 0.77% |
AIMZ Investment Advisors, LLC | 42,085 | $765,000 | 0.37% |
Phocas Financial Corp. | 127,949 | $2,325,000 | 0.35% |
Redhawk Wealth Advisors, Inc. | 34,680 | $630,000 | 0.29% |